6580 72nd Ave N Ste A, Pinellas Park, FL 33781
(727) 440-5612 | zaidi@aandpcare.com
Addiction and Psychiatric Care
6580 72nd Ave N Ste A, Pinellas Park, FL 33781
(727) 440-5612 | zaidi@aandpcare.com
Most Insurances Accepted
Please confirm coverage by calling your Insurance
SPRAVATO®, the only FDA-approved nasal spray for adults with treatment-resistant depression, reduces depression symptoms when two or more oral antidepressants haven’t worked.
SPRAVATO® can be taken with or without an oral antidepressant. SPRAVATO® reduces depression symptoms when oral antidepressants haven’t worked:
• SPRAVATO® works differently by acting on glutamate
• Glutamate is a chemical messenger found in the brain that is thought
to help balance well-being and depression
• The exact way SPRAVATO® works is unknown
SPRAVATO® may cause serious side effects, including sleepiness (sedation), fainting, dizziness, spinning sensation, anxiety, or feeling disconnected from yourself, your thoughts, feelings, space and time (dissociation), and breathing problems (respiratory depression and respiratory arrest).
The Most Common Side Effects of SPRAVATO®:
• feeling anxious
• lack of energy
• increased blood pressure
• feeling disconnected from yourself, your thoughts, feelings and things around you
• vomiting
• feeling drunk
• headache
• feeling very happy or excited
• dizziness
• nausea
• feeling sleepy
• spinning sensation
• decreased feeling of sensitivity (numbness)
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
You will administer SPRAVATO® nasal spray yourself under the supervision of a healthcare provider at a certified
SPRAVATO® treatment center.
For the first month, you’ll take SPRAVATO® twice per week, then once per week for the second month. After that, you and your provider will determine if treatment should be continued and will have the flexibility to decide your treatment frequency.
In clinical studies of adults with MDSI, those who took SPRAVATO® and an oral antidepressant experienced a greater reduction of depression symptoms at 24 hours compared with those who received a placebo plus an oral antidepressant.